NASSCOM Submits Comments to Ministry of Health and Family Welfare on the draft Medical Devices Rules, 2022

Terms of use

Terms of Use

The use of this site and the content contained therein is governed by the Terms of Use. When you use this site you acknowledge that you have read the Terms of Use and that you accept and will be bound by the terms hereof and such terms as may be modified from time to time.

All text, graphics, audio, design and other works on the site are the copyrighted works of nasscom unless otherwise indicated. All rights reserved.
Content on the site is for personal use only and may be downloaded provided the material is kept intact and there is no violation of the copyrights, trademarks, and other proprietary rights. Any alteration of the material or use of the material contained in the site for any other purpose is a violation of the copyright of nasscom and / or its affiliates or associates or of its third-party information providers. This material cannot be copied, reproduced, republished, uploaded, posted, transmitted or distributed in any way for non-personal use without obtaining the prior permission from nasscom.
The nasscom Members login is for the reference of only registered nasscom Member Companies.
nasscom reserves the right to modify the terms of use of any service without any liability. nasscom reserves the right to take all measures necessary to prevent access to any service or termination of service if the terms of use are not complied with or are contravened or there is any violation of copyright, trademark or other proprietary right.
From time to time nasscom may supplement these terms of use with additional terms pertaining to specific content (additional terms). Such additional terms are hereby incorporated by reference into these Terms of Use.

Disclaimer

The Company information provided on the nasscom web site is as per data collected by companies. nasscom is not liable on the authenticity of such data.
nasscom has exercised due diligence in checking the correctness and authenticity of the information contained in the site, but nasscom or any of its affiliates or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this site. The information from or through this site is provided "as is" and all warranties express or implied of any kind, regarding any matter pertaining to any service or channel, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement are disclaimed. nasscom and its affiliates and associates shall not be liable, at any time, for any failure of performance, error, omission, interruption, deletion, defect, delay in operation or transmission, computer virus, communications line failure, theft or destruction or unauthorised access to, alteration of, or use of information contained on the site. No representations, warranties or guarantees whatsoever are made as to the accuracy, adequacy, reliability, completeness, suitability or applicability of the information to a particular situation.
nasscom or its affiliates or associates or its employees do not provide any judgments or warranty in respect of the authenticity or correctness of the content of other services or sites to which links are provided. A link to another service or site is not an endorsement of any products or services on such site or the site.
The content provided is for information purposes alone and does not substitute for specific advice whether investment, legal, taxation or otherwise. nasscom disclaims all liability for damages caused by use of content on the site.
All responsibility and liability for any damages caused by downloading of any data is disclaimed.
nasscom reserves the right to modify, suspend / cancel, or discontinue any or all sections, or service at any time without notice.

For any grievances under the Information Technology Act 2000, please get in touch with Grievance Officer, Mr. Anirban Mandal at data-query@nasscom.in.

New

See all

No notification found.

NASSCOM Submits Comments to Ministry of Health and Family Welfare on the draft Medical Devices Rules, 2022

Devika Agarwal

@DevikaAgarwal

September 30, 2022

Public Policy

307

On September 20, 2022, the Ministry of Health and Family Welfare (MoHFW) released the draft Medical Devices (Amendment) Rules, 2022 (draft Rules) for public consultation until September 27, 2022. The draft Rules seek to simplify the extant registration process for Class A (non-sterile and/or non-measuring) medical devices (“Class A NSNM devices”) by allowing self-certification and self-attestation by manufacturers/importers of such devices. NASSCOM submitted its feedback to MoHFW on the draft Rules on September 27, 2022.

The main recommendations made by NASSCOM are as follows:

Need for clarity on the applicability of the various Chapters of the Medical Devices Rules, 2017 (MDR 2017):

The draft Rules clarify that chapters IV (‘Manufacture of medical devices for sale or for distribution') and V (‘Import of medical devices’) of the MDR 2017 will not apply to Class A NSNM devices. However, the draft Rules do not clarify how Chapters VI (‘Labelling of medical devices’), VII (‘Clinical investigation of medical devices and clinical performance evaluation of new in vitro diagnostic medical device’), VIII (‘Import or manufacture medical device which does not have its predicate device’) and IX (‘Duties of Medical Device Officer, Medical Device Testing Officer and Notified Body’) will apply.

Need for clarity on the treatment of the license fee already paid by manufacturers and importers as per Chapter IIIA, MDR 2017:

In February 2020, the MoHFW introduced Chapter IIIA to the MDR 2017 which required all manufacturers and importers of Class A medical devices (including NSNM devices) to register their devices by October 1, 2022, by paying specific license fees. Since the draft Rules propose a registration process which dispenses with licensing fees, there is a need to clarify how the license fees already paid will be treated going forward.

Need for guidance on the classification of Class A NSNM devices:

At present, the draft Rules do not provide any guidance on what amounts to non- sterile and non-measuring devices under Class A of the First Schedule of the MDR 2017. As per industry feedback, the lack of such guidance could lead to erroneous classification which may risk safety.

Need for exemption from stock and sale license for Class A NSNM devices:

The draft Rules need to clarify whether there is an exemption from the requirement to obtain a stock and sale license for Class A NSNM devices which are low-risk, primarily sold through mass channels and do not require any special storage or handling. An exemption will reduce unnecessary compliance burden on the sellers of such devices and ensure maximum reach of such devices.

[The full text of NASSCOM’s recommendations is appended. For any queries related to this submission, please reach out to dagarwal@nasscom.in and sudipto@nasscom.in with a copy to policy@nasscom.in]

Health Tech medical devices e-pharmacies Start-ups e-commerce

Disclaimer

That the contents of third-party articles/blogs published here on the website, and the interpretation of all information in the article/blogs such as data, maps, numbers, opinions etc. displayed in the article/blogs and views or the opinions expressed within the content are solely of the author's; and do not reflect the opinions and beliefs of NASSCOM or its affiliates in any manner. NASSCOM does not take any liability w.r.t. content in any manner and will not be liable in any manner whatsoever for any kind of liability arising out of any act, error or omission. The contents of third-party article/blogs published, are provided solely as convenience; and the presence of these articles/blogs should not, under any circumstances, be considered as an endorsement of the contents by NASSCOM in any manner; and if you chose to access these articles/blogs , you do so at your own risk.

Download Attachment

Devika Agarwal

Call for Inputs: SEBI's consul...

Swapnil